Back to Annual Meeting

Back to Annual Meeting

APHA Scientific Session and Event Listing

Ann Mahony, MPH, SAMHSA/CSAT, 1 Choke Cherry Rm 5-1067, Rockville, MD 20857, 240-276-2969, ann.mahony@samsha.hhs.gov

This session describes the development of the principles and parallels between substance abuse disorders (SUDS) and other chronic disease models. Historically, the leading causes of death were reported as diseases such as heart disease, cancer, stroke, and diabetes which failed to make the behavioral connections of the contributors of death such as tobacco, poor diet and lack of physical activity, alcohol consumption, motor vehicle crashes, fire arms, sexual behavior, and illicit drug use. In the first paper, Norman Giesbrecht describes recommendations for giving evidence-based attention to alcohol and other risk factors and social conditions to promote effective interventions and alcohol controls, linking epidemiology with practice, and building on effective initiatives for chronic disease intervention. In the second paper, Ann Mahony links illicit drug abuse data with risk factors for chronic disease to build substance abuse treatment intervention models. In the third paper, Michael Botticelli describes how the state of Massachusetts links its data to build a chronic disease model for the state's substance abuse treatment system through strategic planning. In the final session, Christy Scott present data which review the challenges of treating substance use disorders (SUDS) within a chronic care model and to explore the feasibility of managing SUDS to determine the effectiveness on patient outcomes.

Learning Objectives: At the conclusion of this session, the participant will be able to

• Describe the principles and parallels between substance abuse disrders and other chronic disease models;
• Analyze the similarities and differences between an alcohol and illicit drug chronic model; and
• Discuss how one state models uses a strategic planning process and one chronic care model provides monitoring to achieve outcomes.

Keywords: Chronic Diseases, Other Drugs

Presenting author's disclosure statement:

Any relevant financial relationships? No